Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2016 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Zentalis Pharmaceuticals Inc. | 12 | Q2 2024 | 48.0% |
BLACK STONE MINERALS | 11 | Q3 2023 | 82.2% |
Evelo Bioseciences Inc | 11 | Q3 2023 | 7.3% |
BIOSIG TECH INC | 10 | Q2 2023 | 6.7% |
Clearpoint Neuro Inc (Frmly MRI INTERVENTIONS INC) | 10 | Q3 2023 | 3.5% |
UNITY BIOTECHNOLOGY INC | 8 | Q4 2022 | 23.1% |
Neuroon Medical Technologies | 8 | Q2 2024 | 4.8% |
MSCI ACWI ETF | 7 | Q2 2024 | 89.6% |
EXACT SCIENCES CORP | 7 | Q2 2023 | 4.5% |
UNITY BIOTECHNOLOGY INC | 6 | Q2 2024 | 5.5% |
View Mayo Clinic's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
VENTURE LENDING & LEASING IV INC | March 16, 2005 | 6,000 | 6.0% |
View Mayo Clinic's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-09-03 |
13F-HR | 2024-08-12 |
13F-HR | 2024-05-13 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-05 |
13F-HR/A | 2023-02-09 |
13F-HR | 2023-01-26 |
13F-HR | 2021-08-12 |
View Mayo Clinic's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.